As of 2024-07-27, the Intrinsic Value of Boston Scientific Corp (BSX) is
45.41 USD. This BSX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 74.92 USD, the upside of Boston Scientific Corp is
%.
The range of the Intrinsic Value is 29.60 - 92.28 USD
45.41 USD
Intrinsic Value
BSX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
29.60 - 92.28 |
45.41 |
-39.4% |
| DCF (Growth 10y) |
37.02 - 106.27 |
54.61 |
-27.1% |
| DCF (EBITDA 5y) |
39.99 - 57.82 |
50.59 |
-32.5% |
| DCF (EBITDA 10y) |
46.73 - 70.12 |
59.58 |
-20.5% |
| Fair Value |
30.17 - 30.17 |
30.17 |
-59.74% |
| P/E |
46.17 - 58.74 |
47.19 |
-37.0% |
| EV/EBITDA |
35.71 - 52.94 |
45.48 |
-39.3% |
| EPV |
17.42 - 24.22 |
20.82 |
-72.2% |
| DDM - Stable |
12.85 - 46.25 |
29.55 |
-60.6% |
| DDM - Multi |
22.07 - 62.27 |
32.66 |
-56.4% |
BSX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
110,145.88 |
| Beta |
0.79 |
| Outstanding shares (mil) |
1,470.18 |
| Enterprise Value (mil) |
118,435.88 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.46% |
| Cost of Debt |
4.34% |
| WACC |
8.12% |